Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Graff, J. N.
  • Alumkal, J. J.
  • Drake, C. G.
  • Thomas, G. V.
  • Redmond, William
  • Farhad, M.
  • Cetnar, J. P.
  • Ey, F. S.
  • Bergan, R. C.
  • Slottke, R.
  • Beer, T. M.

publication date

  • August 2016

journal

  • Oncotarget  Journal

subject areas

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Drug Administration Schedule
  • Drug Resistance, Neoplasm
  • Humans
  • Hypothyroidism
  • Male
  • Middle Aged
  • Myositis
  • Neoplasm Metastasis
  • Phenylthiohydantoin
  • Programmed Cell Death 1 Receptor
  • Prostate-Specific Antigen
  • Prostatic Neoplasms, Castration-Resistant
  • Remission Induction
scroll to property group menus

Research

keywords

  • Immune response
  • Immunity
  • Immunology and Microbiology Section
  • PD-1
  • enzalutamide
  • immunotherapy
  • prostate cancer
scroll to property group menus

Identity

PubMed Central ID

  • PMC5288150

International Standard Serial Number (ISSN)

  • 1949-2553

Digital Object Identifier (DOI)

  • 10.18632/oncotarget.10547

PubMed ID

  • 27429197
scroll to property group menus

Additional Document Info

start page

  • 52810

end page

  • 52817

volume

  • 7

issue

  • 33

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support